Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors: An immunohistochemical study

Archives of Pathology and Laboratory Medicine

Volumn 126, Issue 7, 2002, Pages 816-822

  Boyle, Jenny L ^a   Haupt, Helen M ^a   Stern, Jere B ^a   Multhaupt, Hinke A B ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GLYCOPROTEIN GP 100; MONOPHENOL MONOOXYGENASE; PROTEIN S 100; VIMENTIN;

ARTICLE; CANCER DIAGNOSIS; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROFIBROMA; PERIPHERAL NERVE TUMOR; PROTEIN EXPRESSION;

ANTIGENS, CD34; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; NERVE SHEATH NEOPLASMS; S100 PROTEINS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 0036311384     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Molecular pathology of malignant melanoma
2. Role of molecular biology in diagnostic pathology of melanoma
3. Comparison of immunohistochemical labeling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB-45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma
4. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants
5. HMB-45: A review
6. Comparative analysis of the in-vivo expression of tyrosinase, MART-1/Melan-A and gp100 in metastatic melanoma lesions: Implications for immunotherapy
7. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
8. T311: An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues
9. Expression of gp100, MART-1, tyrosinase and S100 in paraffin-embedded primary melanomas and locoregional, lymph node and visceral metastases implications for diagnosis and immunotherapy
10. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: A comparison of the novel T311 antibody (anti-tyrosinase) with S100, HMB-45 and A103 (antimelan-A)
11. A case of pigmented dermatofibrosarcoma protuberans (Bednar tumor)
12. Storiform neurofibromas of the skin, pigmented and nonpigmented
13. Malignant pigmented spinal nerve root schwannoma metastasizing in the brain and viscera
14. Bednar tumor (pigmented dermatofibrosarcoma protuberans): An analysis of six cases
15. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): A pathologic, ultrastructural and immunohistochemical study
16. Abnormal pigmentation of schwannoma attributed to excess production of neuromelanin-like pigment
17. Pigmented (melanotic) neurofibroma: A clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients
18. Melanotic schwannoma of soft tissues: Electron-microscopic observations and review of the literature
19. Cytology of melanotic schwannoma in a fine needle aspirate and pleural fluid: A case report
20. Melanotic schwannoma
21. Melanotic schwannoma: Clinical and ultrastructural studies of three cases with evidence of intracellular melanin synthesis
22. Melanotic schwannoma of bone: Clinicopathologic, immunohistochemical and ultrastructural features of a rare primary bone tumor
23. Primary melanocytic schwannoma of cervical sympathetic chain
24. Desmoplastic malignant melanoma: An immunocytochemical study of 25 cases
25. Desmoplastic and spindle cell malignant melanoma: An immunohistochemical study
26. HMB-45 negative spindle cell malignant melanoma
27. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
28. Malignant melanomas simulating various types of soft tissue tumors
29. Mediastinal tumors of peripheral nervous system origin
30. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy
31. Morphological and immunophenotypic variations in malignant melanoma
32. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution
33. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
34. Analysis of microphthalmia transcription factor expression in normal tissues and tumors and comparison of its expression with S100 protein, gp100 and tyrosinase in desmoplastic malignant melanoma
35. Origin of the desmoplasia in melanoma
36. Anomalous cytokeratin expression in malignant melanoma: One and two dimensional Western blot analysis and immunohistochemical survey of 100 melanomas
37. Antigen retrieval techniques in immunohistochemistry: Comparison of different methods
38. Antigen retrieval immunohistochemistry: Past, present, and future
39. Benign tumors of peripheral nerves
40. The fourth week
41. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment
42. Malignant peripheral nerve sheath tumor: A clinicopathologic study of 120 cases
43. Malignant peripheral nerve sheath tumor: An immunohistochemical study in relation to ultrastructural features
44. Malignant peripheral nerve sheath tumor: An immunohistochemical study of 62 cases
45. Malignant peripheral nerve-sheath tumors (malignant schwannomas): An immunohistochemical study of 29 cases
46. Immunohistochemical characterization of malignant peripheral nerve sheath tumors
47. Malignant epithelioid schwannoma of the skin showing partial HMB-45 positivity